Study details
Enrolling now
MDMA-assisted Cognitive Processing Therapy Versus Cognitive Processing Therapy for Veterans With Severe Posttraumatic Stress Disorder
Patricia Suppes
NCT IDNCT05837845ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
30
Study length
about 2.9 years
Ages
18+
Locations
1 site in CA
What this study is about
Researchers are testing whether MDMA-assisted Cognitive Processing Therapy (MDMA-aCPT) is more effective than Cognitive Processing Therapy (CPT) in treating PTSD. The trial will compare these two treatments to see which one works best for veterans with severe PTSD.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Participate in Cognitive Processing Therapy
- 2.Participate in MDMA-assisted Cognitive Processing Therapy (MDMA-aCPT)
- 3.Take MDMA
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Oral
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug routes
oral
Endpoints
Secondary: Change in Quality of Life Enjoyment and Satisfaction Questionnaire
Body systems
Psychiatry / Mental Health